Wird geladen...
Current landscape of frontline and relapsed follicular lymphoma trials
Abstract: Treatment for follicular lymphoma (FL) has rapidly advanced in recent years, with a broad array of novel agents demonstrating promising results, particularly in the relapsed or refractory (R/R) setting. Key emerging therapies include chimeric antigen receptor T-cell therapy, bispecific ant...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2025-11-01
|
| Schriftenreihe: | Blood Neoplasia |
| Online Zugang: | http://www.sciencedirect.com/science/article/pii/S2950328025000664 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|